| World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia … A Hasan, P Falkai, T Wobrock, J Lieberman, B Glenthoj, WF Gattaz, ... The World Journal of Biological Psychiatry 13 (5), 318-378, 2012 | 468 | 2012 |
| World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of … A Hasan, P Falkai, T Wobrock, J Lieberman, B Glenthoj, WF Gattaz, ... The world journal of biological psychiatry 14 (1), 2-44, 2013 | 467 | 2013 |
| Causes and consequences of the gender difference in age at onset of schizophrenia H Häfner, W an der Heiden, S Behrens, WF Gattaz, M Hambrecht, ... Schizophrenia bulletin 24 (1), 99-113, 1998 | 459* | 1998 |
| Mental disorders in megacities: findings from the São Paulo megacity mental health survey, Brazil LH Andrade, YP Wang, S Andreoni, CM Silveira, C Alexandrino-Silva, ... PloS one 7 (2), e31879, 2012 | 394 | 2012 |
| World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia P Falkai, T Wobrock, J Lieberman, B Glenthoj, WF Gattaz, HJ Möller, ... The World Journal of Biological Psychiatry 6 (3), 132-191, 2005 | 388 | 2005 |
| Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial OV Forlenza, BS Diniz, M Radanovic, FS Santos, LL Talib, WF Gattaz The British Journal of Psychiatry 198 (5), 351-356, 2011 | 347 | 2011 |
| Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder PV Nunes, OV Forlenza, WF Gattaz The British Journal of Psychiatry 190 (4), 359-360, 2007 | 326 | 2007 |
| Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group DP Hibar, LT Westlye, NT Doan, N Jahanshad, JW Cheung, CRK Ching, ... Molecular psychiatry 23 (4), 932-942, 2018 | 287 | 2018 |
| World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia R Tandon, RH Belmaker, WF Gattaz, JJ Lopez-Ibor Jr, A Okasha, B Singh, ... Schizophrenia research 100 (1-3), 20-38, 2008 | 280 | 2008 |
| Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study DO Rumi, WF Gattaz, SP Rigonatti, MA Rosa, F Fregni, MO Rosa, ... Biological psychiatry 57 (2), 162-166, 2005 | 247 | 2005 |
| Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy WF Gattaz, M Köllisch, T Thuren, JA Virtanen, PKJ Kinnunen Biological Psychiatry 22 (4), 421-426, 1987 | 237 | 1987 |
| An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia H Häfner, S Behrens, J De Vry, WF Gattaz Psychiatry research 38 (2), 125-134, 1991 | 223 | 1991 |
| Increased serum phospholipase A₂ activity in schizophrenia: A replication study. WF Gattaz, CV Hübner, TJ Nevalainen, T Thuren, PK Kinnunen Biological psychiatry, 1990 | 223 | 1990 |
| World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia. Part 2: long-term treatment P Falkai, T Wobrock, J Lieberman, B Glenthoj, WF Gattaz, HJ Möller Archives of Clinical Psychiatry (São Paulo) 33, 65-100, 2006 | 220 | 2006 |
| Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: a systematic review with network meta-analysis AR Brunoni, A Chaimani, AH Moffa, LB Razza, WF Gattaz, ZJ Daskalakis, ... JAMA psychiatry 74 (2), 143-152, 2017 | 211 | 2017 |
| Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia D Martins-de-Souza, WF Gattaz, A Schmitt, C Rewerts, G Maccarrone, ... European archives of psychiatry and clinical neuroscience 259 (3), 151-163, 2009 | 196 | 2009 |
| Pain perception threshold in major depression G Adler, WF Gattaz Biological psychiatry 34 (10), 687-689, 1993 | 194 | 1993 |
| Increased platelet phospholipase A2 activity in schizophrenia WF Gattaz, A Schmitt, A Maras Schizophrenia research 16 (1), 1-6, 1995 | 193 | 1995 |
| Diagnosis and biomarkers of predementia in Alzheimer's disease OV Forlenza, BS Diniz, WF Gattaz BMC medicine 8 (1), 1-14, 2010 | 177 | 2010 |
| Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia A Breier, PH Berg, JH Thakore, D Naber, WF Gattaz, P Cavazzoni, ... American Journal of Psychiatry 162 (10), 1879-1887, 2005 | 174 | 2005 |
Breno Satler DinizCenter for Addiction and Mental Health, University of Toronto, Toronto, ON, CanadaVerified email at camh.ca
